KOLMARBNH CO LTD |
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Sales 2024 * | 643B 468M 0 | Sales 2025 * | 673B 491M 0 | Capitalization | 441B 321M 0 |
|---|---|---|---|---|---|
| Net income 2024 * | 45B 32.8M - | Net income 2025 * | 52B 37.91M - | EV / Sales 2024 * | 0.73 x |
| Net Debt 2024 * | 31B 22.6M 0 | Net Debt 2025 * | 17.5B 12.76M 0 | EV / Sales 2025 * | 0.68 x |
| P/E ratio 2024 * |
9.96
x | P/E ratio 2025 * |
8.59
x | Employees | - |
| Yield 2024 * |
2.03% | Yield 2025 * |
2.03% | Free-Float | 39.44% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Kwang-Il Kim
AUD | Comptroller/Controller/Auditor | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Byeong-Mook Kim
BRD | Director/Board Member | 63 | 17-03-23 |
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
KolmarBNH Co., Ltd, formerly MIRAE ASSET NO.2 SPECIAL PURPOSE ACQUISITION COMPANY, is a Korea-based company principally engaged in manufacture and distribution of health functional foods, cosmetics and pharmaceuticals. The Company mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The Company also produces cosmetics using natural extracts, and other pharmaceuticals. The Company also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
Sector
Food Processing
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.90% | 7.69B | |
| +0.34% | 7.29B | |
| +9.12% | 6.24B | |
| -9.51% | 3.65B | |
| -12.58% | 3.43B | |
| -13.90% | 1.16B | |
| +8.48% | 961M | |
| -41.81% | 918M | |
| -19.51% | 841M |
